enVVeno Medical (NVNO) announced the appointment of Jennifer Bright as CFO, effective May 19. Bright brings more than 25 years of financial and strategic leadership experience built across several commercial-stage medical device and pharmaceutical companies including Biolase, Spectrum Pharmaceuticals, Apria Healthcare, Smile Brands, and Teleflex Medical, as well as technical accounting and auditing experience at PricewaterhouseCoopers LLP.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVNO:
- enVVeno Medical publishes three-year VenoValve data
- enVVeno Medical announces publication of VenoValve first-in-human trial data
- Envveno Medical Corporation (NVNO) Q1 Earnings Cheat Sheet
- enVVeno Medical reports Q1 EPS (22c) vs. (31c) last year
- enVVeno Medical expects capital to fund company through several milestones